Vaginal Ring Could Reduce The Risk Of HIV Infection In Women
A study conducted by the International Partnership for Microbicides has concluded that the a vaginal ring that releases an an experimental anti-AIDS drug called dapirivine can reduce the risk of HIV infection by 27-31 percent in all women, and 37-61 percent in women over the age of 25.
Two studies on the ring–which is worn for four weeks and then removed, similarly to those used for birth control–were conducted on a total of 4,588 women in countries like Malawi, South Africa, Uganda and Zimbabwe. It was not determined if the ring was was more effective in women over the age of 25 for biological reasons or because they were more likely to use it properly.
Zeda Rosenberg, the CEO of the reason medications International Partnership for Microbicides notes that innovations like this ring are particularly important in countries with high rates of HIV is because often women in those countries don’t feel as though they are in a position where they can persuade their partners to use condoms.
These women need a discrete form of HIV prevention that they can use on their own so they don’t have to rely on their partners to do the right thing to protect them from infection. They also need something that is easy to use, as studies have shown that younger women are less likely to take something like PReP (an HIV prevention pill) that they have to take every day.